31P MR spectroscopy and in vitro markers of oxidative capacity in type 2 diabetes patients
详细信息 查看全文
- 作者：S. F. E. Praet (1)
H. M. M. De Feyter (2)
R. A. M. Jonkers (1) (2)
K. Nicolay (2)
C. van Pul (3) (4)
H. Kuipers (1)
L. J. C. van Loon (1)
J. J. Prompers (2) - 关键词：31P MRS ; VO2peak ; Muscle biopsy ; Fiber ; type ; Oxidative enzymes ; Type 2 diabetes ; Mitochondrial dysfunction
- 刊名：Magnetic Resonance Materials in Physics, Biology and Medicine
- 出版年：2006
- 出版时间：December 2006
- 年：2006
- 卷：19
- 期：6
- 页码：321-331
- 全文大小：275KB
- 参考文献：1. Lowell BB, Shulman GI (2005) Mitochondrial dysfunction and type 2 diabetes. Science 307:384-87 10.1126/science.1104343">CrossRef
2. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI (2004) Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350:664-71 10.1056/NEJMoa031314">CrossRef
3. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW, Shulman GI (2003) Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300:1140-142 10.1126/science.1082889">CrossRef
4. Kelley DE, He J, Menshikova EV, Ritov VB (2002) Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51:2944-950 10.2337/diabetes.51.10.2944">CrossRef
5. Short KR, Nair KS, Stump CS (2004) Impaired mitochondrial activity and insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350:2419-421; author reply 2419-421 10.1056/NEJM200406033502320">CrossRef
6. Simoneau JA, Kelley DE (1997) Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. J Appl Physiol 83:166-71
7. van Loon LJ, Goodpaster BH (2006) Increased intramuscular lipid storage in the insulin-resistant and endurance-trained state. Pflugers Arch 451:606-16 10.1007/s00424-005-1509-0">CrossRef
8. Arnold DL, Matthews PM, Radda GK (1984) Metabolic recovery after exercise and the assessment of mitochondrial function in vivo in human skeletal muscle by means of 31P NMR. Magn Reson Med 1:307-15 10.1002/mrm.1910010303">CrossRef
9. Mattei JP, Bendahan D, Cozzone P (2004) P-31 magnetic resonance spectroscopy. A tool for diagnostic purposes and pathophysiological insights in muscle diseases. Reumatismo 56:9-4
10. Radda GK, Odoom J, Kemp G, Taylor DJ, Thompson C, Styles P (1995) Assessment of mitochondrial function and control in normal and diseased states. Biochim Biophys Acta 1271:15-9
11. Kemp GJ, Taylor DJ, Thompson CH, Hands LJ, Rajagopalan B, Styles P, Radda GK (1993) Quantitative analysis by 31P magnetic resonance spectroscopy of abnormal mitochondrial oxidation in skeletal muscle during recovery from exercise. NMR Biomed 6:302-10
12. Radda GK, Kemp GJ, Styles P, Taylor DJ (1993) Control of oxidative phosphorylation in muscle. Biochem Soc Trans 21(Pt 3):762-64
13. Arnold DL, Taylor DJ, Radda GK (1985) Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy. Ann Neurol 18:189-96 10.1002/ana.410180205">CrossRef
14. Kemp GJ, Radda GK (1994) Quantitative interpretation of bioenergetic data from 31P and 1H magnetic resonance spectroscopic studies of skeletal muscle: an analytical review. Magn Reson Q 10:43-3
15. Larson-Meyer DE, Newcomer BR, Hunter GR, Joanisse DR, Weinsier RL, Bamman MM (2001) Relation between in vivo and in vitro measurements of skeletal muscle oxidative metabolism. Muscle Nerve 24:1665-676 10.1002/mus.1202">CrossRef
16. McCully KK, Fielding RA, Evans WJ, Leigh JS, Jr, Posner JD (1993) Relationships between in vivo and in vitro measurements of metabolism in young and old human calf muscles. J Appl Physiol 75:813-19
17. Argov Z, De Stefano N, Taivassalo T, Chen J, Karpati G, Arnold DL (1997) Abnormal oxidative metabolism in exercise intolerance of undetermined origin. Neuromuscul Disord 7:99-04 10.1016/S0960-8966(97)00426-4">CrossRef
18. Bendahan D, Desnuelle C, Vanuxem D, Confort-Gouny S, Figarella-Branger D, Pellissier JF, Kozak-Ribbens G, Pouget J, Serratrice G, Cozzone PJ (1992) 31P NMR spectroscopy and ergometer exercise test as evidence for muscle oxidative performance improvement with coenzyme Q in mitochondrial myopathies. Neurology 42: 1203-208
19. Massie BM, Conway M, Yonge R, Frostick S, Sleight P, Ledingham J, Radda G, Rajagopalan B (1987) 31P nuclear magnetic resonance evidence of abnormal skeletal muscle metabolism in patients with congestive heart failure. Am J Cardiol 60:309-15
20. Pipinos II, Shepard AD, Anagnostopoulos PV, Katsamouris, A, Boska MD (2000) Phosphorus 31 nuclear magnetic resonance spectroscopy suggests a mitochondrial defect in claudicating skeletal muscle. J Vasc Surg 31:944-52 10.1067/mva.2000.106421">CrossRef
21. Bendahan D, Confort-Gouny S, Kozak-Reiss G, Cozzone PJ (1990) Heterogeneity of metabolic response to muscular exercise in humans. New criteria of invariance defined by in vivo phosphorus-31 NMR spectroscopy. FEBS Lett 272:155-58 10.1016/0014-5793(90)80472-U">CrossRef
22. Iotti S, Lodi R, Frassineti C, Zaniol P, Barbiroli B (1993) In vivo assessment of mitochondrial functionality in human gastrocnemius muscle by 31P MRS The role of pH in the evaluation of phosphocreatine and inorganic phosphate recoveries from exercise. NMR Biomed 6:248-53
23. Lodi R, Kemp GJ, Iotti S, Radda GK, Barbiroli B (1997) Influence of cytosolic pH on in vivo assessment of human muscle mitochondrial respiration by phosphorus magnetic resonance spectroscopy. Magn Reson Mator Phy. 5:165-71 10.1007/BF02592248">CrossRef
24. Roussel M, Bendahan D, Mattei JP, Le Fur Y, Cozzone PJ (2000) 31P magnetic resonance spectroscopy study of phosphocreatine recovery kinetics in skeletal muscle: the issue of intersubject variability. Biochim Biophys Acta 1457:18-6
25. Quistorff B, Johansen L, Sahlin K (1993) Absence of phosphocreatine resynthesis in human calf muscle during ischaemic recovery. Biochem J 291(Pt 3):681-86
26. Haseler LJ, Lin AP, Richardson RS (2004) Skeletal muscle oxidative metabolism in sedentary humans: 31P-MRS assessment of O2 supply and demand limitations. J Appl Physiol 97:1077-081
27. Home P (2005) Contributions of basal and post-prandial hyperglycaemia to micro- and macrovascular complications in people with type 2 diabetes. Curr Med Res Opin 21:989-98 10.1185/030079905X49662">CrossRef
28. Young JL, Pendergast DR, Steinbach J (1991) Oxygen transport and peripheral microcirculation in long-term diabetes. Proc Soc Exp Biol Med 196:61-8
29. Marin P, Anersson B, Krotkiewski M, Bjorntorp P (1994) Muscle fiber composition and capillary density in women and men with NIDDM. Diabetes Care 17:382-86 10.2337/diacare.17.5.382">CrossRef
30. Girach A, Vignati L (2006) Diabetic microvascular complications–can the presence of one predict the development of another? J Diabetes Complicat 20:228-37 10.1016/j.jdiacomp.2006.03.001">CrossRef
31. Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-53 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S">CrossRef
32. Zhang YY, Johnson MC, 2nd, Chow N, Wasserman K (1991) Effect of exercise testing protocol on parameters of aerobic function. Med Sci Sports Exerc 23:625-30
33. Weber CT, Janicki JS, McElroy PA (1986) Cardiopulmonary exercise testing (CPX) testing. W.B. Saunders, Philadelphia
34. Richardson RS, Frank LR, Haseler LJ (1998) Dynamic knee-extensor and cycle exercise: functional MRI of muscular activity. Int J Sports Med 19:182-87 10.1055/s-2007-971901">CrossRef
35. Vanhamme L, van den Boogaart A, Van Huffel S (1997) Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 129:35-3 10.1006/jmre.1997.1244">CrossRef
36. Taylor DJ, Styles P, Matthews PM, Arnold DA, Gadian DG, Bore P, Radda GK (1986) Energetics of human muscle: exercise-induced ATP depletion. Magn Reson Med 3:44-4 10.1002/mrm.1910030107">CrossRef
37. Taylor DJ, Bore PJ, Styles P, Gadian DG, Radda GK (1983) Bioenergetics of intact human muscle. A 31P nuclear magnetic resonance study. Mol Biol Med 1:77-4
38. Lawson JW, Veech RL (1979) Effects of pH and free Mg2+ on the / K eq of the creatine kinase reaction and other phosphate hydrolyses and phosphate transfer reactions. J Biol Chem 254:6528-537
39. Boska M (1994) ATP production rates as a function of force level in the human gastrocnemius/soleus using 31P MRS. Magn Reson Med 32:1-0
40. Kemp GJ, Thompson CH, Barnes PR, Radda GK (1994) Comparisons of ATP turnover in human muscle during ischemic and aerobic exercise using 31P magnetic resonance spectroscopy. Magn Reson Med 31:248-58
41. Cho M, Webster SG, Blau HM (1993) Evidence for myoblast-extrinsic regulation of slow myosin heavy chain expression during muscle fiber formation in embryonic development. J Cell Biol 121:795-10 10.1083/jcb.121.4.795">CrossRef
42. Gosker HR, van Mameren H, van Dijk PJ, Engelen MP, van der Vusse GJ, Wouters EF, Schols AM (2002) Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease. Eur Respir J 19:617-25 10.1183/09031936.02.00762001">CrossRef
43. Argov Z, De Stefano N, Arnold DL (1996) ADP recovery after a brief ischemic exercise in normal and diseased human muscle—a 31P MRS study. NMR Biomed 9:165-72
44. Richardson RS (1998) Oxygen transport: air to muscle cell. Med Sci Sports Exerc 30:53-9
45. Kingwell BA, Formosa M, Muhlmann M, Bradley SJ, McConell GK (2003) Type 2 diabetic individuals have impaired leg blood flow responses to exercise: role of endothelium-dependent vasodilation. Diabetes Care 26:899-04 10.2337/diacare.26.3.899">CrossRef
46. Rasmussen UF, Rasmussen HN, Krustrup P, Quistorff B, Saltin B, Bangsbo J (2001) Aerobic metabolism of human quadriceps muscle: in vivo data parallel measurements on isolated mitochondria. Am J Physiol Endocrinol Metab 280: E301-07
47. Scheuermann-Freestone M, Madsen PL, Manners D, Blamire AM, Buckingham RE, Styles P, Radda GK, Neubauer S, Clarke K (2003) Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes. Circulation 107:3040-046 10.1161/01.CIR.0000072789.89096.10">CrossRef
48. Kent-Braun JA, Ng AV (2000) Skeletal muscle oxidative capacity in young and older women and men. J Appl Physiol 89:1072-078
49. Conley KE, Jubrias SA, Esselman PC (2000) Oxidative capacity and ageing in human muscle. J Physiol 526 (Pt 1):203-10 10.1111/j.1469-7793.2000.t01-1-00203.x">CrossRef
50. Schunk K, Pitton M, Duber C, Kersjes W, Schadmand-Fischer S, Thelen M (1999) Dynamic phosphorus-31 magnetic resonance spectroscopy of the quadriceps muscle: effects of age and sex on spectroscopic results. Invest Radiol 34:116-25 10.1097/00004424-199902000-00004">CrossRef
51. Giudicelli JF, Richer C, Richard C, Thuillez C (1991) Angiotensin converting enzyme inhibition. Systemic and regional hemodynamics in rats and humans. Am J Hypertens 4:258S-62S
52. Scheen AJ (2004) Renin-angiotensin system inhibition prevents type 2 diabetes mellitus Part 2. Overview of physiological and biochemical mechanisms. Diabetes Metab 30:498-05 10.1016/S1262-3636(07)70147-7">CrossRef
53. Bahi L, Koulmann N, Sanchez H, Momken I, Veksler V, Bigard AX, Ventura-Clapier R (2004) Does ACE inhibition enhance endurance performance and muscle energy metabolism in rats?. J Appl Physiol 96:59-4 10.1152/japplphysiol.00323.2003">CrossRef
54. Challiss RA, Hayes DJ, Radda GK (1988) A 31P-NMR study of the acute effects of altered beta-adrenoceptor stimulation on the bioenergetics of skeletal muscle during contraction. Biochem Pharmacol 37:4653-659 - 作者单位：S. F. E. Praet (1)
H. M. M. De Feyter (2)
R. A. M. Jonkers (1) (2)
K. Nicolay (2)
C. van Pul (3) (4)
H. Kuipers (1)
L. J. C. van Loon (1)
J. J. Prompers (2)
1. Department of Movement Sciences, Nutrition and Toxicology Research Institute Maastricht (NUTRIM), Maastricht University, PO Box 616, 6200, MD, Maastricht, The Netherlands
2. Biomedical NMR, Department of Biomedical Engineering, Einhoven University of Technology (TUE), Eindhoven, The Netherlands
3. Department of Clinical Physics, Máxima Medical Center (MMC), Veldhoven, The Netherlands
4. Department of Applied Physics, Eindhoven University of Technology (TUE), Eindhoven, The Netherlands
文摘
Background: Skeletal muscle mitochondrial function in type 2 diabetes (T2D) is currently being studied intensively. In vivo 31P magnetic resonance spectroscopy (31P MRS) is a noninvasive tool used to measure mitochondrial respiratory function (MIFU) in skeletal muscle tissue. However, microvascular co-morbidity in long-standing T2D can interfere with the 31P MRS methodology. Aim: To compare 31P MRS-derived parameters describing in vivo MIFU with an in vitro assessment of muscle respiratory capacity and muscle fiber-type composition in T2D patients. Methods: 31P MRS was applied in long-standing, insulin-treated T2D patients. 31P MRS markers of MIFU were measured in the M. vastus lateralis. Muscle biopsy samples were collected from the same muscle and analyzed for succinate dehydrogenase activity (SDH) and fiber-type distribution. Results: Several 31P MRS parameters of MIFU showed moderate to good correlations with the percentage of type I fibers and type I fiber-specific SDH activity (Pearson’s R between 0.70 and 0.75). In vivo and in vitro parameters of local mitochondrial respiration also correlated well with whole-body fitness levels (VO 2peak) in these patients (Pearson’s R between 0.62 and 0.90). Conclusion: Good correlations exist between in vivo and in vitro measurements of MIFU in long-standing insulin-treated T2D subjects, which are qualitatively and quantitatively consistent with previous results measured in healthy subjects. This justifies the use of 31P MRS to measure MIFU in relation to T2D.